Investigation Overview
April 19, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of ImmuCell Corporation (NASDAQ:ICCC) was announced over potential breaches of fiduciary duties by certain officers and directors at ImmuCell Corporation. The investigation by a law firm concerns whether certain ImmuCell officers and directors breached their fiduciary duties and caused damage...
You must register (for free) or login to view the entire investigation.